J Todd Abrams

Title: J Todd Abrams: Innovator in T Cell Activation

Introduction

J Todd Abrams is a notable inventor based in Narberth, PA (US). He has made significant contributions to the field of immunology, particularly in the activation of T cells. With a total of 2 patents, his work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Abrams' latest patents include a method of activating T cells with a lymphokine known as SAF. This lymphokine can be utilized to activate and stimulate CD3.sup.+, CD4.sup.+ T cells, as well as Sezary leukemic T cells. The lymphokine can be derived from mitogen-stimulated peripheral blood mononuclear cells or the urine of Sezary Syndrome patients. Additionally, it is noted that the lymphokine upregulates interleukin-2 receptors. Another patent focuses on the lymphokine SAF and the method of its production, emphasizing its role in T cell activation.

Career Highlights

Throughout his career, Abrams has worked with esteemed institutions such as The Wistar Institute and the University of Miami. His research has contributed to advancements in understanding T cell behavior and potential therapeutic applications.

Collaborations

Abrams has collaborated with notable individuals in his field, including Elaine C DeFreitas and Elaine DeFreitas. These partnerships have likely enriched his research and innovation efforts.

Conclusion

J Todd Abrams stands out as an inventor whose work in T cell activation holds promise for future medical advancements. His contributions to immunology are noteworthy and reflect his dedication to improving health outcomes.